Your browser doesn't support javascript.
loading
Improving the circulation time and renal therapeutic potency of extracellular vesicles using an endogenous ligand binding strategy.
Liu, Shuyun; Lv, Ke; Wang, Yizhuo; Lou, Peng; Zhou, Pingya; Wang, Chengshi; Li, Lan; Liao, Guangneng; Zhang, Yong; Chen, Younan; Cheng, Jingqiu; Lu, Yanrong; Liu, Jingping.
Affiliation
  • Liu S; NHC Key Laboratory of Transplant Engineering and Immunology, Regenerative Medicine Research Center, Frontiers Science Center for Disease-related Molecular Network, West China Hospital of Sichuan University, Chengdu, China.
  • Lv K; NHC Key Laboratory of Transplant Engineering and Immunology, Regenerative Medicine Research Center, Frontiers Science Center for Disease-related Molecular Network, West China Hospital of Sichuan University, Chengdu, China.
  • Wang Y; NHC Key Laboratory of Transplant Engineering and Immunology, Regenerative Medicine Research Center, Frontiers Science Center for Disease-related Molecular Network, West China Hospital of Sichuan University, Chengdu, China.
  • Lou P; NHC Key Laboratory of Transplant Engineering and Immunology, Regenerative Medicine Research Center, Frontiers Science Center for Disease-related Molecular Network, West China Hospital of Sichuan University, Chengdu, China.
  • Zhou P; NHC Key Laboratory of Transplant Engineering and Immunology, Regenerative Medicine Research Center, Frontiers Science Center for Disease-related Molecular Network, West China Hospital of Sichuan University, Chengdu, China.
  • Wang C; NHC Key Laboratory of Transplant Engineering and Immunology, Regenerative Medicine Research Center, Frontiers Science Center for Disease-related Molecular Network, West China Hospital of Sichuan University, Chengdu, China; Department of Endocrinology and Metabolism, Center for Diabetes and Metabolis
  • Li L; NHC Key Laboratory of Transplant Engineering and Immunology, Regenerative Medicine Research Center, Frontiers Science Center for Disease-related Molecular Network, West China Hospital of Sichuan University, Chengdu, China.
  • Liao G; Animal Center, West China Hospital of Sichuan University, Chengdu, China.
  • Zhang Y; Institutes for Systems Genetics, West China Hospital of Sichuan University, Chengdu, China.
  • Chen Y; NHC Key Laboratory of Transplant Engineering and Immunology, Regenerative Medicine Research Center, Frontiers Science Center for Disease-related Molecular Network, West China Hospital of Sichuan University, Chengdu, China.
  • Cheng J; NHC Key Laboratory of Transplant Engineering and Immunology, Regenerative Medicine Research Center, Frontiers Science Center for Disease-related Molecular Network, West China Hospital of Sichuan University, Chengdu, China.
  • Lu Y; NHC Key Laboratory of Transplant Engineering and Immunology, Regenerative Medicine Research Center, Frontiers Science Center for Disease-related Molecular Network, West China Hospital of Sichuan University, Chengdu, China.
  • Liu J; NHC Key Laboratory of Transplant Engineering and Immunology, Regenerative Medicine Research Center, Frontiers Science Center for Disease-related Molecular Network, West China Hospital of Sichuan University, Chengdu, China. Electronic address: liujingping@scu.edu.cn.
J Control Release ; 352: 1009-1023, 2022 12.
Article in En | MEDLINE | ID: mdl-36375619
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Extracellular Vesicles / Kidney Diseases Limits: Animals Language: En Journal: J Control Release Journal subject: FARMACOLOGIA Year: 2022 Document type: Article Affiliation country: China Country of publication: Netherlands
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Extracellular Vesicles / Kidney Diseases Limits: Animals Language: En Journal: J Control Release Journal subject: FARMACOLOGIA Year: 2022 Document type: Article Affiliation country: China Country of publication: Netherlands